Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Head and Neck Neoplasms 1

Interventions

Surveys and Questionnaires 26Blood Specimen Collection 19Radiotherapy 17Gene Expression Profiling 11Immunohistochemistry 9Cetuximab 6Polymerase Chain Reaction 5Nivolumab 5Immunotherapy 5Cisplatin 5Microarray Analysis 4Drug Therapy 4Biopsy 4pembrolizumab 3Tissue Banks 3Therapeutics 3Reverse Transcriptase Polymerase Chain Reaction 3Restraint, Physical 3Radiotherapy, Intensity-Modulated 3Radiation 3Observation 3Interviews as Topic 3Immunologic Techniques 3Immunoenzyme Techniques 3Flow Cytometry 3Chemotherapy, Adjuvant 3Surgical Procedures, Operative 2Quality of Life 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Head and Neck Neoplasms × Tissue Array Analysis × Clear all
NCT00898742 2013-04-02

Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer

Vanderbilt-Ingram Cancer Center

Terminated
58 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡